StockData
Liquidia Corp logo

Liquidia Corp (LQDA) stock

LQDANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 8/3075% above fair value
$56.73+0.36 (+0.64%)

Close on Nov 17, 2026Market cap $5.08BP/E 40.8Yield –

Liquidia ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Liquidia's ebitda for the twelve months ending Jun 30, 2026 was $169.99M. For fiscal 2025 it was -$49.85M. The highest annual figure on record is -$28.19M in fiscal 2021.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$49.85M–
FY2024Dec 31, 2024-$119.10M–
FY2023Dec 31, 2023-$71.21M–
FY2022Dec 31, 2022-$35.12M–
FY2021Dec 31, 2021-$28.19M–
FY2020Dec 31, 2020-$55.96M–
FY2019Dec 31, 2019-$44.26M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$85.82M–
Q1 FY2026Mar 31, 2026$62.00M–
Q4 FY2025Dec 31, 2025$20.11M–
Q3 FY2025Sep 30, 2025$2.07M–
Q2 FY2025Jun 30, 2025-$37.31M–
Q1 FY2025Mar 31, 2025-$34.97M–
Q4 FY2024Dec 31, 2024-$35.59M–
Q3 FY2024Sep 30, 2024-$28.89M–
Q2 FY2024Jun 30, 2024-$27.00M–
Q1 FY2024Mar 31, 2024-$28.31M–
Q4 FY2023Dec 31, 2023-$25.93M–
Q3 FY2023Sep 30, 2023-$14.59M–
Q2 FY2023Jun 30, 2023-$22.53M–
Q1 FY2023Mar 31, 2023-$8.66M–
Q4 FY2022Dec 31, 2022-$5.93M–
Q3 FY2022Sep 30, 2022-$8.43M–
Q2 FY2022Jun 30, 2022-$8.57M–
Q1 FY2022Mar 31, 2022-$13.53M–
Q4 FY2021Dec 31, 2021-$10.49M–
Q3 FY2021Sep 30, 2021-$6.68M–
Q2 FY2021Jun 30, 2021-$5.95M–
Q1 FY2021Mar 31, 2021-$7.39M–
Q4 FY2020Dec 31, 2020-$14.96M–
Q3 FY2020Sep 30, 2020-$14.09M–
Q2 FY2020Jun 30, 2020-$12.77M–
Q1 FY2020Mar 31, 2020-$13.91M–

More Liquidia figures

See a number that looks wrong?